CDC Estimates Indicate 24% Decrease in US Drug Overdose Deaths

According to the latest estimates from the U.S. Centers for Disease Control and Prevention, drug overdose deaths in the United States have seen an annual decrease but still account for the leading cause of death among individuals aged 18-44.

“Recent data from the CDC’s National Vital Statistics System forecasts a nearly 24 percent reduction in drug overdose fatalities in the U.S. for the 12 months ending in September 2024, in comparison to the previous year,” the agency stated in a release on February 25.

Approximately 87,000 drug overdose deaths occurred from October 2023 to September 2024, down from about 114,000 the year before, as per the agency’s figures, which align with fiscal year 2024.

This 87,000 count represents the “lowest number of overdose deaths recorded in any 12-month span since June 2020,” the agency noted.

The CDC attributes this decline in overdose fatalities to several factors, including changes in the availability of illegal drugs, enhanced access to evidence-based treatment for individuals with substance use disorders, and the broad distribution of naloxone, a life-saving medication that can reverse overdoses.

Allison Arwady, the director of CDC’s National Center for Injury Prevention and Control, referred to the predicted drop in overdose deaths by over 27,000 in a single year as “unprecedented,” which translates to saving more than 70 lives each day.

Related Stories

“Thanks to CDC’s public health investments, our enhanced data and laboratory systems for overdose response, and our collaborations with public safety officials across all states, we are able to identify emerging drug threats more swiftly and support public health prevention and response initiatives in communities nationwide,” she commented.

Despite the notable decrease in provisional death statistics, drug overdoses continue to be the primary cause of death among Americans aged 18 to 44, according to the CDC.

In 2017, President Donald Trump proclaimed the opioid overdose crisis a public health emergency.

The CDC credited the ongoing public health investments spurred by this designation, which remains in effect, and the subsequent congressional funding for having “transformed the nation’s capacity to utilize data for saving lives.”

The agency noted that deaths related to opioid use, particularly those involving synthetic opioids like fentanyl, constitute a significant portion of overall drug overdose fatalities.

At that time, the White House described the tariffs as “essential to hold China, Mexico, and Canada accountable for their commitments to curb the influx of dangerous drugs into the U.S.”

Moreover, China continues to play a critical role in the flow of fentanyl into the United States. A report from a House committee released last year revealed that Chinese firms are responsible for the production of nearly all illicit fentanyl precursors, the essential components fueling the global illicit fentanyl trading.

The report further indicated that the Chinese communist regime subsidizes the manufacturing and export of illegal fentanyl precursors through tax rebates, fails to prosecute those involved in fentanyl production, and has a vested interest in perpetuating the fentanyl crisis.

This proposed legislation “would enhance the process for inspecting vehicles, trucks, and cargo containers for fentanyl and other contraband at both the Northern and Southern borders,” it explained.

To achieve this, the act “will require U.S. Customs and Border Protection (CBP) to evaluate new detection pilot projects, factoring in cost efficiency, wait times, and existing infrastructure necessities at land entry points,” it stated.